This study revealed both quantitative—as evidenced by decreased numbers of non-proliferating early progenitors—and qualitative differences—characterized by an IFN signature in SLE, which is known to drive loss of function and depletion of HSPCs. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.